help_outline Skip to main content

News / Articles

Protocol of the Development of a Core Outcome Set for Ischemic Stroke in Clinical Trials of Chinese

Qianwen Xie et al.  | Published on 11/14/2020
Ischemic stroke (IS) seriously impacts the quality of life of survivors. Chinese medicine (CM) has been developed for more than 2000 years and plays a key role in the treatment of ischemic stroke. Many Chinese medicine clinical trials have been conducted; however, the heterogeneity of outcome measurements and reporting limits implications of the findings in clinical practice and health policy development. Therefore, it is important to develop a core outcome set (COS) that should be used and reported in trials for ischemic stroke treated by Chinese medicine. This protocol describes the process of developing the IS-CM-COS. Read more here.

All News / Articles